相关实验视频

Updated: May 11, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

在活体中设计的CAR-T细胞疗法:从COVID-19 mRNA疫苗中汲取的教训

Sikun Meng¹, Tomoaki Hara¹, Yutaka Miura²

¹Department of Medical Data Science, Center of Medical Innovation and Translational Research, Osaka University Graduate School of Medicine, Yamadaoka 2-2, Suita, Osaka 565-0871, Japan.

International journal of molecular sciences

|April 17, 2025

概括

使者RNA (mRNA) 和脂质纳米粒子 (LNP) 技术为改进仿真抗原受体T细胞 (CAR-T) 治疗提供了新的途径,特别是在固体瘤中. 这种方法旨在克服目前CAR-T的局限性,以获得更好的癌症治疗.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
生物技术是生物技术.
分子医学是分子医学.

背景情况:

化学抗原受体T细胞 (CAR-T) 疗法已经改变了癌症治疗,但面临着诸如向固体瘤和确保细胞持久性等挑战.
在COVID-19大流行期间mRNA疫苗和脂质纳米粒子 (LNP) 输送系统的成功展示了它们快速开发和高效输送的潜力.
这些mRNA-LNP技术为解决CAR-T疗法的现有局限性提供了一个新的框架.

研究的目的:

探索mRNA-LNP技术的应用,以在体内设计CAR-T细胞.
确定克服当前CAR-T治疗局限性的策略,特别是在固体瘤中.
通过使用mRNA-LNP进展来讨论未来加强CAR-T功能和安全的方向.

主要方法:

审查基于mRNA的CAR工程的最新进展.
针对CAR-T疗法的优化脂质纳米粒子 (LNP) 输送系统的分析.
探索改善体内CAR-T细胞功能和安全性的策略.

主要成果:

mRNA-LNP技术显示了提高CAR-T疗效的潜力,特别是在对抗固体瘤方面.
最近在基于mRNA的CAR工程和LNP交付方面取得的进展显示出改善CAR-T功能的前景.
这种方法可能会导致更通用和更容易获得的CAR-T疗法.

结论:

对于推进CAR-T疗法,mRNA-LNP技术具有显著的前景,解决了固体瘤治疗的关键挑战.
进一步开发mRNA设计,LNP优化和体内工程策略至关重要.
这种创新方法可以使CAR-T疗法成为一种更具适应性和广泛适用的癌症治疗方法.

关键词:

卡特-T疗法是一种治疗方法.免疫反应调节免疫反应调节脂质纳米颗粒的使用方法通过mRNA技术的使用.在mRNA疫苗的使用中.

更多相关视频

Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models

Author Spotlight: Enhancing CAR-T Cell Function in Syngeneic Tumor Models

Published on: February 2, 2024

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...